Extracorporeal Membrane Oxygenation Market - By Modality (Venoarterial, Veno-venous, Arteriovenous), By Application (Cardiac, Respiratory, Extracorporeal Cardiopulmonary Resuscitation), By Patient Population (Infant, Pediatric, Adult) & Global Forecast, 2023 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationExtracorporeal Membrane Oxygenation Market - By Modality (Venoarterial, Veno-venous, Arteriovenous), By Application (Cardiac, Respiratory, Extracorporeal Cardiopulmonary Resuscitation), By Patient Population (Infant, Pediatric, Adult) & Global Forecast, 2023 – 2032
Extracorporeal Membrane Oxygenation Market Size
Extracorporeal Membrane Oxygenation Market size was valued at more than USD 490 million in 2022 and is poised to register over 3.4% CAGR between 2023 and 2032.
Extracorporeal membrane oxygenation (ECMO) is a life-saving treatment that helps people who can't breathe or pump blood on their own. It's like an artificial heart and lungs that do the work of those organs while they recover. As more people learn about how ECMO can help with serious heart and lung problems, more people will be choosing to use it. Unfortunately, unhealthy habits like smoking, drinking, and not taking care of our bodies are leading to more people getting lung diseases. This problem is especially bad in big countries like China and India, so we can expect to see a lot of demand for ECMO there in the future.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Extracorporeal Membrane Oxygenation Market Size in 2022 | USD 490 Million |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 3% |
| 2032 Value Projection | USD 639 Million |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 145 |
| Tables, Charts & Figures | 196 |
| Segments covered | Modality, Application, Patient Population, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Extracorporeal Membrane Oxygenation Market Trends
In recent years, Europe has seen a sharp increase in heart and lung diseases, and this trend is expected to keep rising. This has prompted governments across the region to take action and launch programs to raise public awareness. One of the most active organizations in this fight is Public Health England (PHE). They've launched major initiatives to help prevent and reduce heart disease. PHE works with local groups to share information about cutting-edge treatments and devices, like ECMO, which can help treat heart disease.
Extracorporeal Membrane Oxygenation Market Analysis
Extracorporeal membrane oxygenation market from veno-arterial (VA) segment held more than USD 220 million in 2022 and is anticipated to reach over USD 290 million by 2032. This is due to its widespread application in treating patients suffering from cardiac arrest, pulmonary embolism, pulmonary hypertension, and other diseases. Therefore, growing applications and product adoption will stimulate the demand for veno-arterial extracorporeal membrane oxygenation.
Respiratory segment dominated the ECMO market accounting for more than 65% business share in 2022. The risk of respiratory failure among patients suffering from various respiratory disorders is a major contributor to segment growth. Additionally, expanding geriatric population base prone to suffer from respiratory illnesses is said to stimulate the market landscape.
Extracorporeal membrane oxygenation market from paediatric segment was valued at over USD 100 million in 2022 is anticipated to reach more than 135 million by 2032. The device is used to treat diverse types of diseases in children, including meconium aspiration syndrome, pneumonia, congenital diaphragmatic hernia (CDH), and respiratory distress syndrome (RDS).
North America extracorporeal membrane oxygenation market accounted for more than 59% in 2022. This is driven by well-developed healthcare infrastructure, rising prevalence of pulmonary diseases and expanding geriatric population base. The regional growth is further enhanced by the presence of a highly developed co-payment and insurance system along with presence of established industry players in the region.
Extracorporeal Membrane Oxygenation Market Share
The global extracorporeal membrane oxygenation market consists of several players including
- Abbott Laboratories
- Fresenius Medical Care AG & Co
- KGaA
- Braile Biomedica
- Edwards Lifesciences Corporation
- Abiomed
- Eurosets
- Getinge AB
- LivaNova PLC
- Medtronic
- MicroPort Scientific Corporation
- Nipro
- SB-Kawasumi Laboratories Inc
- Spectrum Medical,
- Terumo Corporation
Extracorporeal membrane oxygenation market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Modality
- Venoarterial
- Veno-venous
- Arterio-venous
By Application
- Cardiac
- Respiratory
- Extracorporeal cardiopulmonary resuscitation (ECPR)
By Patient Population
- Infant
- Pediatric
- Adult
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Asia Pacific
- China
- Japan
- India
- Taiwan
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- South Africa
- Qatar
- UAE
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy